Superoxide stress identifies neurons at risk in a model of ataxia-telangiectasia

Annals of Neurology

Volumn 49, Issue 5, 2001, Pages 627-635

  Quick, Kevin L ^a   Dugan, Laura L ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; GENE PRODUCT; REACTIVE OXYGEN METABOLITE; SALICYLIC ACID; SUPEROXIDE;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATAXIA TELANGIECTASIA; BASAL GANGLION; CEREBELLUM; CONFOCAL MICROSCOPY; CORPUS STRIATUM; DOPAMINERGIC NERVE CELL; GENE; GENE MUTATION; MOUSE; NONHUMAN; OXIDATION REDUCTION REACTION; PRIORITY JOURNAL; PURKINJE CELL;

ANIMALS; ATAXIA TELANGIECTASIA; BRAIN; DISEASE MODELS, ANIMAL; GENOTYPE; MICE; RISK FACTORS; SUPEROXIDES;

EID: 0035011079     PISSN: 03645134     EISSN: None     Source Type: Journal    
DOI: 10.1002/ana.1005     Document Type: Article

References (41)

1. Rotman G, Shiloh Y. ATM: from gene to function. Hum Mol Genet 1998;7:1555-1563.
2. Woods CG, Taylor AM. Ataxia telangiectasia in the British Isles: the clinical and laboratory features in 70 affected individuals. Q J Med 1992;82:169-179.
3. Crawford TO, Mandir AS, Lefton-Greif MA, et al. Quantitative neurologic assessment of ataxia-telangiectasia. Neurology 2000;54:1505-1509.
4. Shiloh Y. Ataxia-telangiectasia and the Nijmegen breakage syndrome: related disorders but genes apart. Annu Rev Genet 1997;31:635-662.
5. Rotman G, Shiloh Y. ATM: a mediator of multiple responses to genotoxic stress. Oncogene 1999;18:6135-6144.
6. Canman CE, Lim DS, Cimprich KA, et al. Activation of the ATM kinase by ionizing radiation and phosphorylation of p53. Science 1998;81:1677-1679.
7. Banin S, Moyal L, Shieh S, et al. Enhanced phosphorylation of p53 by ATM in response to DNA damage. Science 1998;281: 1674-1677.
8. Rotman G, Shiloh Y. Ataxia-telangiectasia: is ATM a sensor of oxidative damage and stress? Bioessays 1997;19:911-917.
9. Reichenbach J, Schubert R, Schwan C, et al. Anti-oxidative capacity in patients with ataxia telangiectasia. Clin Exp Immunol 1999;117:535-539.
10. Barlow C, Dennery PA, Shigenaga MK, et al. Loss of the ataxia-telangiectasia gene product causes oxidative damage in target organs. Proc Natl Acad Sci USA 1999;96:9915-9919.
11. Viera L, Ye YZ, Estevez AG, Beckman JS. Immunohistochemical methods to detect nitrotyrosine. Methods Enzymol 1999; 301:373-381.
12. Halliwell B, Zhao K, Whiteman M. Nitric oxide and peroxynitrite: the ugly, the uglier and the not so good: a personal view of recent controversies. Free Radic Res 1999;31: 651-669.
13. Copp RP, Wisniewski T, Hentatai F, et al. Localization of alpha-tocopherol transfer protein in the brains of patients with ataxia with vitamin E deficiency and other oxidative stress related neurodegenerative disorders. Brain Res 1999;822:80-87.
14. Delatycki MB, Williamson R, Forrest SM. Friedreich ataxia: an overview. J Med Genet 2000;37:1-8.
15. Herzog KH, Chong MJ, Kapsetaki M, et al. Requirement for Atm in ionizing radiation-induced cell death in the developing central nervous system. Science 1998;280:1089-1091.
16. Barlow C, Hirotsune S, Paylor R, et al. Atm-deficient mice: a paradigm of ataxia telangiectasia. Cell 1996;86:159-171.
17. Kuljis RO, Xu Y, Aguila MC, Baltimore D. Degeneration of neurons, synapses, and neuropil and glial activation in a murine Atm knockout model of ataxia-telangiectasia. Proc Natl Acad Sci USA 1997;94:12688-12693.
18. Eilam R, Peter Y, Elson A, et al. Selective loss of dopaminergic nigro-striatal neurons in brains of Atm-deficient mice. Proc Natl Acad Sci USA 1998;95:12653-12656.
19. Farina L, Uggetti C, Ottolini A, et al. Ataxia-telangiectasia: MR and CT findings. J Comput Assist Tomogr 1994;18:724-727.
20. Sardanelli F, Parodi RC, Ottonello C, et al. Cranial MRI in ataxia-telangiectasia. Neuroradiology 1995;37:77-82.
21. Gatti RA, Vinter HV. Cerebellar pathology in ataxia-telangiectasia: the significance of basket cells. Kroc Found Ser 1985;19:225-232.
22. McCabe DR, Maher TJ, Acworth IN. Improved method for the estimation of hydroxyl free radical levels in vivo based on liquid chromatography with electrochemical detection. J Chromatogr B 1997;691:23-32.
23. Schulz JB, Henshaw DR, Siwek D, et al. Involvement of free radicals in excitotoxicity in vivo. J Neurochem 1995;64:2239-2247.
24. Ohlemiller KK, Dugan LL. Elevation of reactive oxygen species following ischemia-reperfusion in mouse cochlea observed in vivo. Audiol Neurootol 1999;4:219-228.
25. Murakami K, Kondo T, Kawase M, et al. Mitochondrial susceptibility to oxidative stress exacerbates cerebral infarction that follows permanent focal cerebral ischemia in mutant mice with manganese Superoxide dismutase deficiency. J Neurosci 1998; 18:205-213.
26. Bindokas VP, Jordan J, Lee CC, Miller RJ. Superoxide production in rat hippocampal neurons: selective imaging with hydroethidine. J Neurosci 1996;16:1324-1336.
27. Benov L, Sztejnberg L, Fridovich I. Critical evaluation of the use of hydroethidine as a measure of Superoxide anion radical. Free Radic Biol Med 1998;25:826-831.
28. Budd SL, Castilho RF, Nicholls DG. Mitochondrial membrane potential and hydroethidine-monitored Superoxide generation in cultured cerebellar granule cells. FEBS Lett 1997;415:21-24.
29. Prehn JH. Mitochondrial transmembrane potential and free radical production in excitotoxic neurodegeneration. Naunyn Schmiedebergs Arch Pharmacol 1998;357:316-322.
30. Scanlon JM, Aizenman E, Reynolds IJ. Effects of pyrroloquinoline quinone on glutamate-induced production of reactive oxygen species in neurons. Eur J Pharmacol 1997;326:67-74.
31. Kaur H, Whiteman M, Halliwell B. Peroxynitrite-dependent aromatic hydroxylation and nitration of salicylate and phenylalanine: is hydroxyl radical involved? Free Radic Res 1997;26:71-82..
32. Halliwell B, Kaur H. Hydroxylation of salicylate and phenylalanine as assays for hydroxyl radicals: a cautionary note visited for the third time. Free Radic Res 1997;27:239-244.
33. Beal MF. Mitochondria, free radicals, and neurodegeneration. Curr Opin Neurobiol 1996;6:661-666.
34. Simonian NA, Coyle JT. Oxidative stress in neurodegenerative diseases. Annu Rev Pharmacol Toxicol 1996;36:83-106.
35. Sen CK. Redox signaling and the emerging therapeutic potential of thiol antioxidants. Biochem Pharmacol 1998;55:1747-1758.
36. Ratan RR, Baraban JM. Apoptotic death in an in vitro model of neuronal oxidative stress. Clin Exp Pharmacol Physiol 1995; 22:309-310.
37. Greenlund LJ, Deckwerth TL, Johnson, EM Jr. Superoxide dismutase delays neuronal apoptosis: a role for reactive oxygen species in programmed neuronal death. Neuron 1995;14:303-315.
38. Choi DW. Excitotoxic cell death. J Neurobiol 1992;23:1261-1276.
39. Melov S, Coskun PE, Wallace DC. Mouse models of mitochondrial disease, oxidative stress, and senescence. Mutat Res 1999;434:233-242.
40. Beckman KB, Ames BN. The free radical theory of aging matures. Physiol Rev 1998;78:547-581.
41. Harding AE. Vitamin E and the nervous system. Crit Rev Neurobiol 1987;3:89-103.